FBXO5 and cervical squamous intraepithelial neoplasia: To determine whether reduced EMI1 expression may contribute to early disease development, we silenced EMI1 in non-malignant, non-transformed cellular contexts (i.e., models of early disease development) and assessed CIN as above.